Detection of Gram-Negative &bgr;-Lactamase Producing Pathogens in the Clinical Lab

By  

Current Pharmaceutical Design, Vol. 19, Iss. 2, 2013-01 ,pp. : 250-256

Bentham Science Publishers

Access to resources Recommend Favorite

VIP as a Potential Therapeutic Agent in Gram Negative Sepsis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 4, 2012-12 ,pp. : 308-315

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence for tumor necrosis factor as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis

By Campanile F.   Giampietri A.   Grohmann U.   Belladonna M.L.   Fioretti M.C.   Puccetti P.  

European Journal of Pharmacology, Vol. 307, Iss. 2, 1996-06 ,pp. : 191-199

Elsevier

Access to resources Recommend Favorite

The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms

By Hagihara Mao   Crandon Jared L   Nicolau David P  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 221-233

Informa Healthcare

Access to resources Recommend Favorite

Clinical Impact of the Over-Expression of Efflux Pump in Nonfermentative Gram-Negative Bacilli, Development of Efflux Pump Inhibitors

By  

Current Drug Targets, Vol. 9, Iss. 9, 2008-01 ,pp. : 797-807

Bentham Science Publishers

Access to resources Recommend Favorite